Ignite Creation Date:
2025-12-24 @ 10:35 PM
Ignite Modification Date:
2026-03-03 @ 2:32 AM
Study NCT ID:
NCT00627835
Status:
WITHDRAWN
Last Update Posted:
2016-07-20
First Post:
2008-02-14
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Dose Escalation Trial of Neoadjuvant Sorafenib and Concurrent Sorafenib, Cisplatin and Radiation in Locally Advanced Squamous Cell Carcinomas of the Head and Neck (SCCHN)
Sponsor:
British Columbia Cancer Agency
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
OZM-003
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Dr Stephen Chia
Old Organization:
British Columbia Cancer Agency